Preliminary study of 11C-choline PET/CT for T staging of locally advanced nasopharyngeal carcinoma: Comparison with 18F-FDG PET/CT

Journal of Nuclear Medicine

Volumn 52, Issue 3, 2011, Pages 341-346

  Wu, Hu Bing ^a   Wang, Quan Shi ^a   Wang, Ming Fang ^a   Zhen, Xiaokang ^a   Zhou, Wen Lan ^a   Li, Hong Sheng ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

11C choline; 18F FDG; Nasopharyngeal carcinoma; PET CT; T staging

Indexed keywords

CHOLINE C 11; FLUORODEOXYGLUCOSE F 18; CARBON; CHOLINE; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BRAIN METASTASIS; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMAGE DISPLAY; MALE; NASOPHARYNX CARCINOMA; ORBIT METASTASIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SKULL BASE TUMOR; CANCER INVASION; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; EVALUATION; IMAGE SUBTRACTION; METHODOLOGY; MIDDLE AGED; NASOPHARYNX TUMOR; PATHOLOGY; PILOT STUDY; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; REPRODUCIBILITY; SCINTISCANNING;

ADULT; AGED; CARBON RADIOISOTOPES; CHOLINE; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PILOT PROJECTS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SUBTRACTION TECHNIQUE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79952777156     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.110.081190     Document Type: Article

References (31)

1. Guigay J. Advances in nasopharyngeal carcinoma. Curr Opin Oncol. 2008; 20:264-269. (Pubitemid 351507545)
2. Afqir S, Ismaili N, Errihani H. Concurrent chemoradiotherapy in the management of advanced nasopharyngeal carcinoma: current status. J Cancer Res Ther. 2009;5:3-7.
3. O'Donnell HE, Plowman PN, Khaira MK, Alusi G. PET scanning and gamma knife radiosurgery in the early diagnosis and salvage "cure" of locally recurrent nasopharyngeal carcinoma. Br J Radiol. 2008;81:e26-e30.
4. Zhang GY, Hu WH, Liu LZ, et al. Comparison between PET/CT and MRI in diagnosing lymph node metastasis and N staging of nasopharyngeal carcinoma [in Chinese]. Zhonghua Zhong Liu Za Zhi. 2006;28:381-384.
5. Chua ML, Ong SC, Wee JT, et al. Comparison of 4 modalities for distant metastasis staging in endemic nasopharyngeal carcinoma. Head Neck. 2009;31:346-354.
6. Liu FY, Lin CY, Chang JT, et al. 18F-FDG PET can replace conventional work-up in primary M staging of nonkeratinizing nasopharyngeal carcinoma. J Nucl Med. 2007;48:1614-1619. (Pubitemid 47572708)
7. 18F-fluorodeoxyglucose positron emission tomography. Int J Radiat Oncol Biol Phys. 2005;62:501-507.
8. Ng SH, Chan SC, Yen TC, et al. Staging of untreated nasopharyngeal carcinoma with PET/CT: comparison with conventional imaging work-up. Eur J Nucl Med Mol Imaging. 2009;36:12-22.
9. 18F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosis. Br J Radiol. 2008;81:291-298.
10. 11C]choline. J Nucl Med. 1997;38:842-847.
11. 18F]fluorodeoxyglucose, and 11C-choline positron-emission tomography. AJNR. 2008;29:1176-1182.
12. 1H-MRS. J Neurooncol. 2003;62:329-338.
13. 18F-FDG PET/CT 1.0. J Nucl Med. 2006;47:885-895.
14. 11C]iodomethane: a remarkably simple captive solvent method. Nucl Med Biol. 2000;27:529-532.
15. Zheng XK, Chen LH, Wang QS, et al. Influence of FDG-PET on computed tomography-based radiotherapy planning for locally recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2007;69:1381-1388.
16. Gordin A, Golz A, Daitzchman M, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography imaging in patients with carcinoma of the nasopharynx: diagnostic accuracy and impact on clinical management. Int J Radiat Oncol Biol Phys. 2007;68:370-376. (Pubitemid 46694160)
17. 18F-FDG PET-CT scans in both diagnosis and radiotherapy treatment planning in patients with head and neck cancer: advantage on target volume and critical organ delineation. Head Neck. 2009;31:461-467.
18. 14C]choline and its incorporation into acetylcholine and phosphatidylcholine in a human cholinergic neuroblastoma cell line. Brain Res. 1992;585:169-176.
19. Yorek MA, Dunlap JA, Spector AA, Ginsberg BH. Effect of ethanolamine on choline uptake and incorporation into phosphatidylcholine in human Y79 retinoblastoma cells. J Lipid Res. 1986;27:1205-1213. (Pubitemid 17233751)
20. 18F choline PET/CT in the preoperative staging of prostate cancer in patients with intermediate or high risk of extracapsular disease: a prospective study of 130 patients. Radiology. 2010;254:925-933.
21. Steuber T, Schlomm T, Heinzer H, et al. [F(18)]-fluoroethylcholine combined inline PET-CT scan for detection of lymph-node metastasis in high risk prostate cancer patients prior to radical prostatectomy: Preliminary results from a prospective histology-based study. Eur J Cancer. 2010;46:449-455.
22. 11C-choline PET/CT using multimodality fusion techniques. J Nucl Med. 2009;50:1585-1593.
23. 18F-FDG PET. J Nucl Med. 2008;49:1245-1248.
24. 18F]FDG PET/CT. Eur J Nucl Med Mol Imaging. 2006;33:1285-1289.
25. 18F-FDG PET imaging in brain tumours. Nucl Med Commun. 2008;29:354-358.
26. Kwee SA, Coel MN, Lim J, Ko JP. Combined use of F-18 fluorocholine positron emission tomography and magnetic resonance spectroscopy for brain tumor evaluation. J Neuroimaging. 2004;14:285-289. (Pubitemid 38781403)
27. 11C-choline as contrast agents in positron emission tomography imaging-guided stereotactic biopsy sampling of gliomas. J Neurosurg. 2003;99:474-479.
28. Kwee SA, Ko JP, Jiang CS, Watters MR, Coel MN. Solitary brain lesions enhancing at MR imaging: evaluation with fluorine 18 fluorocholine PET. Radiology. 2007;244:557-565. (Pubitemid 47080889)
29. Tateishi U, Yamaguchi U, Maeda T, et al. Staging performance of carbon-11 choline positron emission tomography/computed tomography in patients with bone and soft tissue sarcoma: comparison with conventional imaging. Cancer Sci. 2006;97:1125-1128. (Pubitemid 44322564)
30. van den Brekel MWM, Runne RW, Smeele LE, Tiwari RM, Snow GB, Castelijns JA. Assessment of tumour invasion into the mandible: the value of different imaging techniques. Eur Radiol. 1998;8:1552-1557. (Pubitemid 128662692)
31. Daisne JF, Duprez T, Weynand B, et al. Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. Radiology. 2004;233:93-100.